Subsequent Events	12 Months Ended
Dec. 31, 2019
Subsequent Events
Subsequent Events	Note 24—Subsequent Events On January 31, 2020, the Company acquired the remaining 20% interest in Hain Lifescience GmbH (Hain) for a purchase price of EUR 20 million (approximately $22.2 million). The Company had previously purchased the first 80% of Hain in October 2018. Hain is located in Nehren, Germany and is integrated into the Bruker CALID Group.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration